← Open Payments lookup

MHD ANAS ALKHATIB: Open Payments

NPI 1528115326 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$453 in 23 payments from 11 companies in 2025. Trend: 2023 $1,261 · 2024 $1,699 · 2025 $453

Food & beverage: $453
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$97
E.R. Squibb & Sons, L.L.C.3$64
Noven Therapeutics, LLC3$61
ViiV Healthcare Company3$49
ABBVIE INC.3$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Neos Therapeutics, LP1$25
Lundbeck LLC1$20
Bausch Health US, LLC1$19
Axsome Therapeutics, Inc.1$19

Products named: INGREZZA, COBENFY, Xelstrym, CABENUVA, VRAYLAR, CAPLYTA, Metadate CD, REXULTI.

Industry payments across GA — which companies pay providers there.